Effect of the chemotactic peptide on the subsequent superoxide releasing response in human polymorphonuclear leukocytes.
D000328:Adult; D002118:Calcium / Q000494:pharmacology; D002630:Chemotactic Factors / Q000494:pharmacology*; D003208:Concanavalin A / Q000494:pharmacology; D003571:Cytochalasin B / Q000494:pharmacology; D003573:Cytochrome b Group; D003580:Cytochromes / Q000494:pharmacology; D004151:Dipeptides / Q000494:pharmacology*; D006801:Humans; D037102:Lectins / Q000494:pharmacology; D008715:Methionine / Q000031:analogs & derivatives*; D009239:N-Formylmethionine / Q000031:analogs & derivatives* / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D010100:Oxygen / Q000097:blood*; D013481:Superoxides / Q000097:blood*; D014909:Wheat Germ Agglutinins
D002630:Chemotactic Factors; D003573:Cytochrome b Group; D003580:Cytochromes; D004151:Dipeptides; D037102:Lectins; D014909:Wheat Germ Agglutinins; D003208:Concanavalin A; D013481:Superoxides; C017330:N-formylmethionylphenylalanine; D003571:Cytochalasin B; D009239:N-Formylmethionine; D008715:Methionine; D010100:Oxygen; D002118:Calcium